undamentalytics Newsletter
Sign in

Biorestorative Therapies, Inc. balance sheet

At the end of fiscal 2025, Biorestorative Therapies, Inc. had total assets of $4.1m and shareholders' equity of $356,744. It held $1.5m in cash against $0 of debt.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2011Dec 20112012Dec 20122013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMMar 2026
Cash and equivalents——————————2121123
Receivables———0000000000000
Inventory0000————————————
Total current assets00000010032115111134
Total assets01122221142216131245
Accounts payable0111322220000011
Deferred revenue (current)——000———————————
Total current liabilities43896689141063442
Long-term debt04100001—40—————
Total debt35661244740—0000
Total liabilities4689679101461634——
Shareholders' equity−4−5−7−7−4−5−7−9−13−1111010903
Non-controlling interests and other (assets − liabilities − equity)——————————11—————
Shares outstanding—30m38m——94m122m176m—3m4m4m5m7m9m—

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

Head to head: BRTX vs CRVOBRTX vs CRDFBRTX vs CLNN

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Biorestorative Therapies, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Biorestorative Therapies, Inc.